First Time Loading...

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 7.15 CHF 8.33%
Updated: May 13, 2024

Kuros Biosciences AG
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kuros Biosciences AG
Operating Income Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kuros Biosciences AG
SIX:KURN
Operating Income
-CHf8.7m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Operating Income
-$166m
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Operating Income
-CHf53.6m
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Income
-$222.5m
CAGR 3-Years
14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Operating Income
CHf19.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Operating Income
-CHf803m
CAGR 3-Years
-19%
CAGR 5-Years
-152%
CAGR 10-Years
N/A

See Also

What is Kuros Biosciences AG's Operating Income?
Operating Income
-8.7m CHF

Based on the financial report for Dec 31, 2023, Kuros Biosciences AG's Operating Income amounts to -8.7m CHF.

What is Kuros Biosciences AG's Operating Income growth rate?
Operating Income CAGR 5Y
9%

Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Kuros Biosciences AG have been 9% over the past three years , 9% over the past five years .